CPI Card Group Inc (PMTS,PMTS-T) is expected to report $0.37 for 4Q.
Campbell Soup (CPB) is expected to report $0.74 for 2Q.
Clovis Oncology Inc (CLVSQ) is expected to report $-1.72 for 4Q.
Daktronics (DAKT) is expected to report $0.10 for 3Q.
Diversey Holdings Ltd (DSEY) is expected to report for 4Q.
Ebix Inc (EBIX) is expected to report $0.55 for 4Q.
Gatos Silver Inc (GATO) is expected to report for 4Q.
International Money Express Inc (IMXI) is expected to report $0.42 for 4Q.
International Tower Hill (ITH.T,THM) is expected to report for 4Q.
Jounce Therapeutics Inc (JNCE) is expected to report $-0.09 for 4Q.
Korn Ferry (KFY) is expected to report $0.49 for 3Q.
Life Time Group Holdings Inc (LTH) is expected to report for 4Q.
LifeStance Health Group Inc (LFST) is expected to report for 4Q.
Lipocine Inc (LPCN) is expected to report $-0.03 for 4Q.
Lyra Therapeutics Inc (LYRA) is expected to report for 4Q.
Manitex International Inc (MNTX) is expected to report $0.07 for 4Q.
Minerva Neurosciences Inc (NERV) is expected to report for 4Q.
Neptune Wellness Solutions Inc (NEPT,NEPT-T) is expected to report for 3Q.
Nine Energy Service Inc (NINE) is expected to report $0.29 for 4Q.
NuVista Energy is expected to report $0.67 for 4Q.
Nuvei is expected to report for 4Q.
Oncorus Inc (ONCR) is expected to report for 4Q.
Protara Therapeutics Inc (TARA) is expected to report for 4Q.
Rev Group Inc (REVG) is expected to report $-0.01 for 1Q.
Riley Exploration Permian Inc (REPX) is expected to report for 4Q.
Schmitt Industries Inc (SMIT) is expected to report for 1Q.
Stella-Jones Inc (SJ.T) is expected to report $0.58 for 4Q.
Surface Oncology Inc (SURF) is expected to report $-0.39 for 4Q.
The Children's Place Inc (PLCE) is expected to report $-4.04 for 4Q.
United Natural Foods Inc (UNFI) is expected to report $1.24 for 2Q.
Vera Bradley Inc (VRA) is expected to report $0.15 for 4Q.
VersaBank is expected to report $0.28 for 1Q.
Vertex Inc (VERX) is expected to report for 4Q.
Village Super Market (VLGEA) is expected to report for 2Q.
Vita Coco Co (COCO) is expected to report for 4Q.
Xeris Biopharma Holdings Inc (XERS) is expected to report for 4Q.
Powered by Onclusive and Dow Jones.
ANALYST RATINGS ACTIONS
ACM Research Raised to Overweight From Underweight by Morgan Stanley
Anika Therapeutics Cut to Market Perform From Outperform by Barrington Research
Aptinyx Cut to Neutral From Buy by HC Wainwright & Co.
Artisan Partners Asset Cut to Sell From Neutral by Goldman Sachs
Black Stone Minerals Cut to Sector Weight From Overweight by Keybanc
Cara Therapeutics Shares Tumble Premarket After 4Q Report
CareDx Cut to Equal-Weight From Overweight by Stephens & Co.
Carrols Restaurant Raised to Buy From Hold by Craig-Hallum
Costco Raised to Buy From Neutral by Northcoast Research
Delta Air Raised to Outperform From In-Line by Evercore ISI Group
DraftKings Raised to Buy From Hold by Argus Research
Embark Technology Cut to Neutral From Outperform by Baird
Esperion Therapeutics Raised to Neutral From Underperform by Credit Suisse
Gossamer Bio Cut to Market Perform From Outperform by Raymond James
Joby Aviation Cut to Sell From Hold by Deutsche Bank
Kimbell Royalty Partners Raised to Overweight From Sector Weight by Keybanc
Mercantile Bank Raised to Overweight From Neutral by Piper Sandler
NuSTAR Energy Raised to Buy From Hold by Stifel
Office Properties Incm Tr Cut to Underperform From Sector Perform by RBC Capital
Ovintiv Cut to Market Perform From Outperform by BMO Capital
Qualtrics International Cut to Market Perform From Outperform by BMO Capital
Qualtrics International Cut to Market Perform From Outperform by William Blair
Radius Global Infra Cut to Hold From Buy by Jefferies
TCR2 Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Tesla Cut to Hold by Berenberg
Trimble Cut to Sell From Neutral by Northcoast Research
United Airlines Raised to Outperform From Underperform by Exane BNP Paribas
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
03-08-23 0611ET
